Market Overview

Maxim Group Reiterates Buy on ARIAD Pharmaceuticals, Inc., Lowers PT to $24.00

Share:

Get News First. Profit Faster

upsell-button
With Benzinga Professional get unlimited access to ALL content! PLUS:
  • REALTIME NEWSFEED
  • REALTIME AUDIO NEWS
  • FULL CALENDAR SUITE
  • CHAT WITH OUR NEWS DESK

Latest Ratings for ARIA

DateFirmActionFromTo
Jul 2016BarclaysMaintainsUnderweight
May 2016Cowen & Co.UpgradesMarket PerformOutperform
Mar 2016JMP SecuritiesMaintainsMarket Outperform

View More Analyst Ratings for ARIA
View the Latest Analyst Ratings

Posted-In: News Reiteration Analyst Ratings

 

Related Articles (ARIA)